Hospira Tells Fed. Circ. To Reverse Sedative Patent Loss – Law360

Law360 (March 6, 2019, 10:58 PM EST) — Hospira Inc. asked the Federal Circuit on Tuesday to uphold the validity of a patent for its sedation drug Precedex for the second time this year, arguing that an Illinois federal…

To view the full article, register now.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *